Optiray 160 Interactions
There are 149 drugs known to interact with Optiray 160 (ioversol), along with 7 disease interactions. Of the total drug interactions, 86 are major, and 63 are moderate.
- View Optiray 160 disease interactions (7)
Medications known to interact with Optiray 160
Note: Showing generic names only.
- acebutolol
- acetazolamide
- acyclovir
- adefovir
- aldesleukin
- amikacin
- amikacin liposome
- amiloride
- amiodarone
- amphotericin b
- amphotericin b cholesteryl sulfate
- amphotericin b lipid complex
- amphotericin b liposomal
- atenolol
- bacitracin
- balsalazide
- bendroflumethiazide
- benzthiazide
- betaxolol
- betaxolol ophthalmic
- betiatide
- bisoprolol
- bromfenac
- bumetanide
- capreomycin
- carteolol
- carteolol ophthalmic
- carvedilol
- celecoxib
- chlorothiazide
- chlorthalidone
- cidofovir
- cisplatin
- clofarabine
- colistimethate
- cyclosporine
- deferasirox
- deferoxamine
- dichlorphenamide
- diclofenac
- diflunisal
- dimethyl fumarate
- diroximel fumarate
- disopyramide
- dofetilide
- edetate calcium disodium
- edetate disodium (edta)
- esmolol
- ethacrynic acid
- etidronate
- etodolac
- everolimus
- ibandronate
- ibuprofen
- ibutilide
- ifosfamide
- indapamide
- indomethacin
- inotersen
- iobenguane I 131
- iopanoic acid
- ipodate
- labetalol
- landiolol
- levobetaxolol ophthalmic
- levobunolol ophthalmic
- lifileucel
- lithium
- lutetium lu 177 dotatate
- lutetium lu 177 vipivotide tetraxetan
- mannitol
- meclofenamate
- mefenamic acid
- meloxicam
- mesalamine
- metformin
- methazolamide
- methotrexate
- methoxyflurane
- methyclothiazide
- metipranolol ophthalmic
- metolazone
- metoprolol
- monomethyl fumarate
- moxetumomab pasudotox
- pamidronate
- penbutolol
- penicillamine
- pentamidine
- phenylbutazone
- pindolol
- piroxicam
- plazomicin
- polymyxin b
- polythiazide
- procainamide
- propranolol
- salsalate
- sirolimus
- sodium iodide i-123
- sodium iodide-i-131
- sotalol
- spironolactone
- streptomycin
- streptozocin
- sulfasalazine
- sulindac
- tacrolimus
- telavancin
- temsirolimus
- tenofovir alafenamide
- tenofovir disoproxil
- timolol
- timolol ophthalmic
- tobramycin
- tolmetin
- torsemide
- triamterene
- trichlormethiazide
- tyropanoate
Optiray 160 disease interactions
There are 7 disease interactions with Optiray 160 (ioversol) which include:
- hyperthyroidism
- pheochromocytoma
- sickle cell disease
- myasthenia gravis
- asthma/allergies
- acute renal failure
- cardiovascular disease
Report options
More about Optiray 160 (ioversol)
- Optiray 160 consumer information
- Compare alternatives
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: non-ionic iodinated contrast media
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Visipaque
Visipaque is used for aortography, cerebral arteriography, computed tomography, coronary ...
Optiray 350
Optiray 350 is used for body imaging, cerebral arteriography, coronary arteriography, head imaging ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Ultravist
Ultravist is used for cerebral arteriography, computed tomography, coronary arteriography ...
Plavix
Plavix (clopidogrel) is used to prevent blood clots after a recent heart attack or stroke. Includes ...
Integrilin
Integrilin prevents blood clots or heart attack in people with severe chest pain and in patients ...
Angiomax
Angiomax is used for angina, percutaneous coronary intervention
Eptifibatide
Eptifibatide is used for acute coronary syndrome, angina, heart attack, percutaneous coronary ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.